Reply Fertility (Durham, NC): A Complete Patient Guide

The Research Triangle is one of the most competitive fertility care markets in the South. Between the academic heavyweights at UNC Fertility and Duke Reproductive Medicine, regional practices have to offer something distinctive to attract patients. Reply Fertility, based on Meridian Parkway in Durham, does exactly that — and the distinction is philosophical as much as clinical. Founded in 2015, Reply has built its identity around Restorative Reproductive Medicine (RRM), a science-backed framework that prioritizes identifying and treating the underlying causes of infertility before defaulting to IVF. For the right patient, it is a genuinely different kind of fertility care. For patients seeking IVF as a primary pathway, it is worth understanding what Reply does and does not offer before scheduling a consult. This guide covers the physicians, the services, the outcomes data, and the practical details every Triangle-area patient should know.

Physicians and Clinical Team

Reply Fertility's medical leadership includes four physicians and a substantial support team of advanced-practice providers, nurse midwives, fertility educators, and health coaches — a structure that reflects the clinic's emphasis on education and case management as integral parts of treatment.

Dr. John M. Thorp Jr., MD serves as Medical Director. His CV is among the most academically distinguished in North Carolina reproductive medicine. Thorp holds the Hugh McAllister Distinguished Professorship and serves as Vice Chair of Research in the Department of Obstetrics and Gynecology at UNC Chapel Hill — the flagship public university research program in the state. He completed his medical degree at East Carolina University, his OB/GYN residency and maternal-fetal medicine fellowship at UNC, and holds subspecialty board certification in maternal-fetal medicine in addition to his OB/GYN board certification. He is a Fellow ad eundem of the Royal College of Obstetricians and Gynaecologists in London and served as UNC's principal investigator for the NIH Maternal-Fetal Medicine Units Network, contributing to landmark discoveries on progesterone's role in preventing preterm birth. His clinical interests extend into fertility awareness, prenatal nutrition, and health disparities — the connective tissue between his academic research and Reply's clinical philosophy.

Dr. Kyle Beiter, MD brings surgical subspecialty experience in Restorative Reproductive Medicine to the practice. A board-certified OB/GYN, he completed a fellowship in medical and surgical NaProTechnology at the Pope Paul VI Institute in Omaha — one of a small number of programs in North America that trains physicians specifically in RRM surgical techniques. Before joining Reply, he served as Medical and Surgical Infertility Consultant at Saint Peter's University Hospital in New Brunswick, NJ, and taught at Rutgers Robert Wood Johnson Medical School. He received his medical degree from Ohio State University College of Medicine and holds certification as a Restorative Reproductive Medicine Clinician from the International Institute for Restorative Reproductive Medicine.

Dr. Amina White, MD serves as Director of Medical Professional Development, overseeing clinical training and quality across the practice. Dr. Joseph B. Stanford, MD, MSPH, CFCMC — who holds a Master of Science in Public Health in addition to his medical degree — serves as Interim Director of Restorative Reproductive Medicine and is among the most published academic researchers in the RRM field nationally.

Dr. Kimberly Barrows, MD rounds out the physician team as an RRM clinician. Advanced-practice providers include Samantha Ratcliffe, CNM, WHNP-BC (Certified Nurse Midwife and Women's Health Nurse Practitioner), Amanda Naramore, APRN, and Lisa Brown, DNP, CNM. The nursing and education team — which includes fertility educators, health coaches, and case managers with credentials ranging from BSN to MSc and MPH — plays an unusually large role in the clinical experience compared to conventional fertility practices.

Services and Treatments

Reply Fertility operates within the RRM framework, which defines its service offerings in ways that differ meaningfully from a conventional reproductive endocrinology practice. The core premise: most couples dealing with infertility have between four and six identifiable contributing factors, and RRM seeks to find and address those factors rather than accept an "unexplained infertility" diagnosis or move immediately to IVF.

The clinic's diagnostic workup is accordingly thorough. Hormone panel evaluation, ovulation tracking, cycle charting analysis, and male fertility assessment are all part of initial investigations. Fertility awareness instruction — specifically the Sensiplan method, which Reply brought to North America for the first time — and the clinic's own Listen Fertility™ framework are used to build a detailed picture of each couple's reproductive physiology before treatment begins.

Treatment options include IUI (intrauterine insemination), natural cycle support to optimize conception timing, and minimally invasive surgery to correct anatomical causes of infertility. Laparoscopic and hysteroscopic procedures are performed to address endometriosis, uterine fibroids, polyps, and adhesions — conditions that Reply clinicians view as correctable contributors to infertility rather than incidental findings to be managed around. PCOS, recurrent pregnancy loss, and cervical factor infertility all fall within the practice's scope.

Egg freezing and embryo freezing are available. IVF is offered as part of the service line, though notably not as the automatic first recommendation after initial workup. Gynecological health coaching — encompassing nutrition, sleep, exercise, and stress management — is integrated into care plans. The practice also offers telehealth services for patients in North Carolina and in several other states where Reply has expanded its reach.

What Reply does not offer: the kind of high-volume IVF program with an on-site embryology laboratory performing hundreds of retrievals per year that characterizes dedicated REI practices like UNC Fertility or Carolina Conceptions. Patients whose clinical situation calls primarily for high-complexity IVF — particularly those with diminished ovarian reserve or advanced maternal age — should understand that Reply's model is oriented toward a different patient pathway.

Laboratory and Success Rates

Reply Fertility's outcomes data stands apart from the SART-reporting format familiar to patients evaluating conventional IVF clinics. Rather than SART's per-cycle live birth rates for IVF, Reply publishes its own outcomes within the RRM framework: approximately 50% of enrolled couples achieve pregnancy within 12 months of beginning treatment, with that figure rising to 69% within 18 months. The clinic presents these as comparable to IVF outcomes — a claim supported by peer-reviewed literature on RRM approaches in appropriately selected patient populations, though direct comparison with IVF success rates requires careful interpretation since patient populations differ substantially.

For patients specifically evaluating IVF outcomes, the absence of SART reporting means the clinic's IVF-specific data is not independently audited or publicly available in the same format as SART-reporting programs. Patients who want the granular age-stratified live birth rate data that SART publishes should ask Reply directly about their IVF cycle volumes and outcomes, or explore the broader IVF guide on this site for context on how to evaluate fertility clinic data across different reporting formats.

Patient Experience

Reply Fertility's 4.3-star rating reflects a patient experience defined largely by what does not happen at conventional fertility practices. Patients frequently cite the diagnostic thoroughness — the sense that someone is actually looking for answers rather than managing symptoms — as the practice's most valuable quality. Multiple reviewers note that they came to Reply after unsuccessful cycles elsewhere or after receiving unhelpful "unexplained" diagnoses, and that the detailed workup gave them a framework for their situation that previous care had not. The clinic's attention to communication is also widely noted: same-day phone responses and timely message replies stand out in an industry where phone access is a common pain point.

The educational component is more intensive than at a standard fertility clinic. Fertility awareness instruction, health coaching, and case management are active parts of the treatment model rather than ancillary services. Patients who want to engage deeply with their reproductive health data tend to find this appealing; patients primarily seeking a streamlined clinical pathway to IVF may find it more involved than they anticipated.

The Durham location at 2530 Meridian Parkway, Suite 300 — near Research Triangle Park — is accessible to patients across the Triangle. Reply also serves patients from Holly Springs, Brier Creek, and other Triangle-area communities, and offers telehealth access for patients who cannot travel to Durham. For broader context on fertility care across the state, see our guide to fertility clinics in North Carolina.

Considering At-Home Insemination?

Not every fertility journey begins in a clinic. At-home intracervical insemination (ICI) is a lower-cost, private option that suits patients with no known fertility diagnosis — including single parents by choice, same-sex couples, and people who want to try a few cycles before committing to clinical treatment.

At-home insemination kits like those from MakeAMom come with step-by-step instructions designed for donor or partner sperm. Kits are a one-time purchase that can be reused until conception succeeds, require no clinic visit, and arrive in plain, discreet packaging. Many patients use them as a first step while working toward a fertility consultation — or alongside ovulation tracking while they wait for an appointment slot.

If you have a known fertility diagnosis, have been trying for 12 months without success (six months if you're over 35), or your physician has already recommended IUI or IVF, a board-certified reproductive endocrinologist is the right next step.

Insurance and Financing

North Carolina has no fertility insurance mandate, which means that regardless of where Triangle-area patients seek care, IVF and most fertility treatments are out-of-pocket expenses unless an employer plan explicitly includes fertility benefits. This is the baseline reality for patients in this state. Some larger employers — particularly technology and pharmaceutical companies concentrated in RTP — do offer managed fertility benefits through platforms like Progyny or Carrot; if you work for a larger employer, it is worth reviewing your benefits portal before assuming there is no coverage.

Reply Fertility's care model, with its emphasis on diagnosing and treating underlying causes before moving to IVF, can represent a lower overall cost pathway for couples who do have correctable contributing factors. A laparoscopic surgery to treat endometriosis or a targeted hormone protocol to address luteal phase deficiency carries a different price point than a full IVF cycle. The clinic's fees and insurance team handles benefit verification and cost estimation; patients should ask for a detailed fee breakdown during initial consultation.

For patients who do proceed to IVF, Reply's financial coordinators can outline available financing options. The clinic's fees and insurance page provides the starting point for that conversation.

Frequently Asked Questions

Does Reply Fertility offer IVF?

Yes. IVF is part of Reply Fertility's service line, but it is not the default first recommendation. The clinic's restorative reproductive medicine model emphasizes identifying and treating underlying causes of infertility — including hormonal imbalances, anatomical conditions, and cycle irregularities — before moving to IVF. Patients who have already completed a thorough diagnostic workup elsewhere and are specifically seeking IVF should ask directly about the clinic's IVF volume and how that pathway is structured within their model.

What is Restorative Reproductive Medicine, and how is it different from conventional fertility care?

Restorative Reproductive Medicine (RRM) is a scientific framework that seeks to cooperate with or restore the normal physiology of the reproductive system rather than bypass it. Where conventional fertility care often manages infertility with ovarian stimulation and IVF, RRM investigates and treats the root causes — endometriosis, PCOS, hormonal deficiencies, structural issues — with the goal of enabling natural or minimally assisted conception. Reply Fertility is one of the leading RRM centers in North America and the clinic where several foundational RRM clinical and educational tools were developed.

What success rates does Reply Fertility report?

Reply Fertility is not a SART-reporting clinic in the same way as conventional IVF centers. The clinic's published outcomes within its RRM framework show that approximately 50% of enrolled couples achieve pregnancy within 12 months and 69% within 18 months. These figures are presented in the context of appropriately selected RRM patient populations. For IVF-specific outcomes, the clinic does not publish SART data publicly; patients should request this directly during their consultation.

Is Reply Fertility right for me if I have already done multiple failed IVF cycles?

Reply Fertility has experience working with patients who have had unsuccessful conventional fertility treatments. The clinic's diagnostic framework is designed specifically to identify factors that may have been missed in prior workups. Whether RRM is the appropriate next step depends on your clinical situation — patients with significant embryo quality issues related to age, for example, may have different needs than those with unexplained implantation failure. A consultation at Reply, which begins with a detailed clinical history review, is the best way to assess whether their approach is well-matched to your specific circumstances.